DUBLIN, March 29, 2024 /PRNewswire/ -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to ResearchAndMarkets.com's offering.
Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?
Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size for five years and even further with a later updated report with next years numbers.
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition
2.1 What are Syndromic Multiplex Tests?
2.2 Syndromic Testing - the quiet revolution in diagnostics
2.2.1 Syndromic Testing - more than Panels.
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
3.3 Symptoms and Syndromes
3.3.2 Typical Viral Symptoms
3.3.3 Typical Bacterial Symptoms
3.6 Infectious Disease Diagnostics
3.6.4 PCR-based diagnostics
3.6.5 Metagenomic sequencing
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.11 Certification Body
4.2 The Clinical Laboratory Market Segments
4.2.1 Traditional Market Segmentation
4.2.2 Laboratory Focus and Segmentation
4.2.3 Segmenting the Syndromic Testing Market
4.3.1 Hospital Testing Share
4.3.2.1 Hospital vs. Central Lab
4.3.3 Physician Office Lab's
4.3.4 Physician's and POCT
5.1 Factors Driving Growth
5.1.1 Speed of Diagnosis.
5.1.2 Effect of Syndromic Testing on Costs.
5.1.3 Point of Care Advantage.
5.1.4 Accuracy and Diagnostic Risk.
5.1.6 Improvement in Outcomes.
5.1.7 Impact of the Pandemic.
5.2 Factors Limiting Growth
5.2.2 Administration/reimbursement.
5.2.3 Infectious Disease is Declining But..
5.2.5 Economic Growth improves Living Standards.
5.2.6 Impact of the Pandemic
5.3 Instrumentation, Automation and Diagnostic Trends
5.3.1 Traditional Automation and Centralization
5.3.2 The New Automation, Decentralization and Point of Care
5.3.3 Instruments Key to Market Share
5.3.4 Bioinformatics Plays a Role
5.3.6 Next Generation Sequencing Fuels a Revolution
5.3.7 NGS Impact on Pricing
5.3.8 Whole Genome Sequencing, A Brave New World
5.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
5.3.10 Comparing Syndrome and Targeted Testing
5.3.11 The Multiplex Paradigm Shift
5.3.12 The SepsisSepsis Testing Market - Bellwether for Syndromics 5.3.13 The Single Visit and AntiMicrobial Resistance
5.3.14 Syndromics drives POCT adoption.
6 Syndromic Testing Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 BioMerieux Submits Application for Respiratory, Sore Throat Panel 6.3 Sensible Diagnostics Nabs Award for Respiratory Panel
6.4 Aptitude Medical Systems to Develop At-Home STI Test
6.6 Burst Dx to Deliver Lab-Accurate ELISA-in-a-Cartridge
6.7 OpGen Seeking Approval for UTI Panel 6.8 Altratech to Enter MDx, POC Space by Supplanting PCR
6.9 BIOFIRE Announces New SPOTFIRE System
6.10 Cambridge Nucleomics to Develop 'Nanobait' Tech
6.13 Nanopath Secures Funding to Develop POC Dx 6.14 Genetic Signatures Wins Public Health Wales Contract
6.15 Qiagen Looks to Long-Term Growth
6.18 BforCure to Adapt Rapid PCR Platform for Cancer 6.19 Accelerated Growth for Decentralized Testing
6.20 QuantuMDx Developing Syndromic Panels for European Launch 6.21 Quidel Gains CE Mark for Savanna Analyzer, Respiratory Panel
6.22 QuantumDx Gets CE Mark for Rapid PoC PCR System
6.24 Baebies to Expand Finder Platform
6.26 Binx Health Targeting Clinics, DTC & OTC With STI Tests 6.27 Luminex Lands BARDA Grant to Develop Test for SARS-CoV-2, Flu, RSV
6.28 Molzym, Fraunhofer Developing Rapid Sepsis Diagnostic 6.29 MiRxes Receives Approval for Multiplex SARS-CoV-2, Flu Test
6.30 New Approach Involves Silicon-Based Test for Infectious Disease Screening
6.31 Scanogen's Portable Battery Operated Instrument for 90 Minute Multiplex Test 6.32 Qiagen sees NeuMoDx as Growth Vehicle
6.34 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests 6.35 BioMerieux's BioFire SARS-CoV-2 Respiratory Panel Wins FDA EAU 6.36 Infectious Disease Testing Firm Curative Acquires KorvaLabs
6.37 ChromaCode Raises Additional $10M
6.38 COVID-19 Patients Need Syndromic Testing 6.40 Qiagen Respiratory Panel with Coronavirus Targets Receives CE Mark
6.41 Exact Diagnostics launches respiratory panel control
6.42 bioMerieux submits enhanced BIOFIRE BCID2 Panel to FDA 7 Profiles of Key Syndromic Testing Companies
7.3 Accelerate Diagnostics
7.24 Curetis N.V./Curetis GmbH
7.26 Diagenode Diagnostics
7.44 LightDeck Diagnostics
7.62 Primerdesign (Novacyt)
7.72 Siemens Healthineers
8 The Global Market for Syndromic Multiplex Diagnostics
8.1 Global Market Overview by Country
8.2 Global Market by Syndrome - Overview
8.3 Global Market by Place - Overview
8.4 Global Market by Product - Overview
9 Global Syndromic Multiplex Markets - By Syndrome
12.1 United States Medicare System: Clinical Laboratory Fees Schedule
12.2 The Most Used IVD Assays
12.3 The Highest Grossing Assays
For more information about this report visit https://www.researchandmarkets.com/r/ih0otx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets